Novartis arthritis drug fails to help COVID-19 patients ...Middle East

Novartis's canakinumab failed to help COVID-19 patients survive without invasive ventilation compared with standard therapy, the Swiss drugmaker said on Friday, dashing hopes the arthritis drug could be repurposed during the pandemic. The medicine, approved as Ilaris for juvenile arthritis and other conditions, also did not meet its key secondary endpoint of reducing COVID-19 mortality in a late-phase clinical trial, the Basel-based drugmaker said. Novartis has hoped 11-year-old canakinumab, with $671 million in sales last year, would help COVID-19 patients hit by inflammatory reactions.

Hence then, the article about novartis arthritis drug fails to help covid 19 patients was published today ( Friday 06/11/2020 - 10:35 AM ) and is available on Yahoo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novartis arthritis drug fails to help COVID-19 patients )

Last updated : 06 Nov 2020 clock 10:35 AM

Also on site :

Novartis arthritis drug fails to help COVID-19 patients ...Middle East

Medical helicopter requested for crash that closed Highway 6 in Clear Creek County

Harry Kane feels in the form of his life after firing England to the World Cup

Trump threatens NATO member with sanctions

Milei se consolida como uno de los “mejores amigos” de Trump: así es la apuesta de “Make Argentina Great Again”

Lala Kent refuses to speak about Scheana Shay as feud reaches point of no return

State Department adviser charged with illegally retaining classified records

Healey slams shutdown: ‘Washington needs to get back to work.’

Harry Kane feels in the form of his life after leading England to the World Cup

New Mormon church leader named after death of 101-year-old predecessor

‘It was the internet then, it is AI now’: IMF upgrades U.S. growth outlook but sees ‘echoes’ of late ’90s dot-com boom

Stellantis to Invest $13 Billion to Grow in the United States

Kevin Berger for Congress? Website naming Senate leader’s son draws eyes ahead of redistricting

Homeowners near Forest Hills Stadium sue NYPD, says people 'physically invade' their streets

Lakers’ Adou Thiero shows ‘insane’ athleticism despite knee swelling

Ring’s New Candy Cam Protects What Really Matters This Halloween: Your Treats